post-add

Neuberg Diagnostics Unveils Personalised Genomics Platform 'Geniee'

Geniee provides users with deep insights into how their genes affect their responses to medications, dietary preferences, exercise routines, and nutritional needs.

Neuberg Diagnostics has unveiled its innovative personalised genomics platform, "Geniee – Decode your DNA." The company claims that Geniee is designed to empower individuals with unique genetic insights, helping them make informed health and wellness decisions based on their DNA. As per a press release, this platform offers more than just risk predictions—it’s a comprehensive tool for optimising wellness.

Geniee provides users with deep insights into how their genes affect their responses to medications, dietary preferences, exercise routines, and nutritional needs. By analysing genetic data, users can optimise their diets, identify potential nutrient deficiencies, enhance fitness plans, and proactively manage their health.

At the core of this initiative are the Complete Wellness Genetics Test and the Geniee app, which offer detailed genetic analyses to guide individuals in tailoring their lifestyles for better health. From identifying potential health risks to recommending dietary adjustments, Geniee enables users to take control of their well-being. The app will also provide regular updates, ensuring users receive the latest scientific insights based on their genetic makeup.

Speaking at the launch, Dr GSK Velu, Chairman & Managing Director of Neuberg Diagnostics, emphasised, "We believe personalised healthcare is the future. Geniee empowers individuals by offering invaluable genetic insights, helping them take charge of their health.  

Geniee’s personalised genomic programs focus on early detection of health risks and creating customised health plans based on individual genetic profiles. Leveraging the science of pharmacogenomics, Geniee provides insights into how genetics influence drug responses, helping healthcare providers personalise treatments and reduce the risk of adverse drug reactions.

Highlighting the platform’s impact Dr Sandip Shah, Joint Managing Director of Neuberg Diagnostics said,"Geniee represents a paradigm shift in healthcare, moving away from a one-size-fits-all approach to personalised treatments based on genetic makeup. This service is transforming diagnostics and patient care, reducing ineffective treatments, and lowering the risk of adverse reactions by 30%."

A recent study revealed that the average Indian carries eight genetic variants that directly affect medication response, further underscoring the importance of Geniee in the Indian healthcare landscape.

 

Also Read

Subscribe to our newsletter to get updates on our latest news